Physician profile
Charles Wang
NPI 1811421209
$26,711.05
in general payments reported to CMS, 2019-2025
17 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $8,788 · 2023: $13K · 2024: $2,558 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,650 · Food and Beverage: $5,191 · Travel and Lodging: $5,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,650.00 |
| Food and Beverage | $5,190.96 |
| Travel and Lodging | $5,082.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17,218.33 | 2022-2024 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Microraptor |
| Stryker Corporation | $4,893.62 | 2022-2025 | Nanopass, Salvation, Mako |
| Arthrex, INC. | $1,570.73 | 2023-2025 | |
| Seapearl East, INC | $1,339.54 | 2023-2025 | |
| Exactech, INC. | $733.84 | 2022 | |
| Zimmer Biomet Holdings, INC. | $304.66 | 2023-2025 | Juggerknotless Soft Anchor, Tapestry, Persona |
| Davol INC. | $191.46 | 2024-2025 | Channel Drain |
| Depuy Synthes Sales INC. | $131.42 | 2023-2025 | Vapr, Gryphon Orthocord, Dynacord |
| Kairos Surgical INC | $77.80 | 2023 | |
| Dynasplint Systems INC. | $53.26 | 2025 | Dynasplint |
| Becton, Dickinson and Company | $52.40 | 2024 | Channel Drain |
| Globus Medical, INC. | $40.87 | 2023 | Distal Femur Plate System |
| Ferring Pharmaceuticals INC. | $24.39 | 2025 | Euflexxa |
| Orthofix Medical, INC. | $23.85 | 2025 | Physio-Stim |
| Molnlycke Health Care US, LLC | $21.08 | 2023 | Avance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $17.46 | 2024 | Durolane |
| Kowa Pharmaceuticals America, INC. | $16.34 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.